Navigation Links
Opportunities for Funding US-Israel Cooperation in Innovative Technologies
Date:7/27/2011

TEL AVIV, Israel, July 27, 2011 /PRNewswire/ --

 

The Next Call for Proposals has Been Issued by the BIRD Foundation. Relevant R&D Topics Include but not Limited to: Life Sciences, Cleantech, Communications, Electronics, Software, HLS, etc.

The BIRD Foundation announced its next funding cycle with a call for US-Israel joint project proposals focusing on innovative R&D collaborations between US and Israeli companies. To be considered, a proposal should have significant commercial potential.

The maximum conditional grant per project is up to 50% of the R&D costs associated with the joint project, and no more than $1 million per project.

The application process is web-based and requires prior discussion with the BIRD Foundation.  Executive Summaries are due by Thursday, September 15, 2011. Final full scale proposals are due by Thursday, October 26, 2011. Decisions will be announced by mid December, 2011. Please refer to BIRD's website for submission details - http://www.birdf.com.

Examples of successful BIRD-funded projects include:

ReWalk - Helping Paraplegics to Walk: With support from the BIRD Foundation, Argo Medical Technologies and Allied Orthotics & Prosthetics are working together to develop the ReWalk device that allows a paralyzed patient to "walk" again.

Mobile Travel Tool: MobiMate, a provider of mobile travel services, partnered with Conducive Technology, to develop its newest mobile travel tool, WorldMate Live which predicts travel conflicts for road warriors and automatically provides solutions, often before a traveler even knows there is a potential problem.

New Drug for Gout: KRYSTEXXA(TM) (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients that are refractory to conventional therapy. The drug has been developed by Mountain View Pharmaceuticals, and Bio-technology General (acquired by Savient Pharmaceuticals) and approved by the U.S. Food and Drug Administration.

About the BIRD Foundation

The BIRD (Binational Industrial Research and Development) Foundation works to encourage cooperation between Israeli and American companies in the various areas of technology, and provides free assistance in locating strategic partners from both countries for developing joint products. During its 34 years, the BIRD Foundation has invested in more than 820 projects, which have yielded direct and indirect revenues of about $8 billion.

The BIRD Foundation supports projects without receiving any rights in the participating companies or in the project itself. The financial assistance is repaid as royalties from sales. The Foundation provides support of up to 50% of a project's budget, beginning with R&D and ending with the initial stages of sales and marketing. The Foundation shares the risk and does not demand that the investment be repaid if the project fails to reach the sales stage.

The BIRD Foundation works in full cooperation with the Chief Scientist's Office at the Ministry of Industry, Trade, and Labor in Israel, and with the U.S. Commerce Department's National Institute of Standards and Technology (NIST).

For further inquiries:
Palo Alto, CA - Michal Miasnik, West Coast Representative
Tel: +1-408-398-1288 / michalm@birdf.com
Princeton, NJ - Andrea Yonah East, Coast Representative
Tel: +1-609-356-0305 / andreay@birdf.com

http://www.birdf.com



'/>"/>
SOURCE The BIRD Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Medical Devices Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies
2. Maximizing Pharmaceutical Licensing Opportunities
3. Global Pharmaceutical Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Buyer Spend and Procurement Strategies
4. Reportlinker Adds Global Microbiology Testing Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers
5. Reportlinker Adds Global Hemostasis Diagnostics Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers
6. Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers
7. Reportlinker Adds Transfusion Diagnostic Testing Market: US, Europe, Japan--Emerging Opportunities And Business Expansion Strategies for Suppliers
8. Thomson Reuters Trademark Report Reveals New Challenges and Opportunities for Pharmaceutical Brands
9. 2011 Retail Clinician Education Congress to Offer Exclusive Accreditation and Networking Opportunities for Retail Healthcare Professionals
10. Reportlinker Adds Greece Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017
11. Reportlinker Adds United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
(Date:6/24/2016)... ... June 24, 2016 , ... To ... infrastructure. Most providers, however, are unsure how to move forward, given the need ... define a path forward tailored to an organization’s specific needs. , PYA Principal ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... SpiritQuest Sedona ... heart of West Sedona, surrounded by famous vortex sites: Cathedral Rock, Airport Mesa, and ... partner properties – the Lodge at Sedona as well as the Sedona Rouge, both ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... An ... may expose a possible link between head and neck cancer in individuals with unhealthy ... the study were evaluated based on whether they had gum disease, brushed their teeth ...
(Date:6/23/2016)... ... 23, 2016 , ... SyncDog, Inc. , the leading ... is featured in the current issue of Silicon Review magazine. Silicon ... technology solutions and features them in their magazine. The magazine allows top-level executives ...
Breaking Medicine News(10 mins):